Werbung
Werbung
SUPN
Supernus Pharmaceuticals, Inc.
51.13
USDGesponsert
-0.04
-0.08%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
49.81
-1.32
-2.57%
SUPN Ergebnisberichte
Positives Überraschungsverhältnis
SUPN übertreffen die 29 der letzten 40Schätzungen.
73%
Nächster Bericht
Datum des nächsten Berichts
23. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$199.39M
/$0.26
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+3.79%
/-74.26%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+14.49%
/-65.33%
Supernus Pharmaceuticals, Inc. earnings per share and revenue
On 04. Nov. 2025, SUPN reported earnings of 1.01 USD per share (EPS) for Q3 25, beating the estimate of 0.60 USD, resulting in a 67.83% surprise. Revenue reached 192.10 million, compared to an expected 182.47 million, with a 5.28% difference. The market reacted with a -17.35% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of 0.26 USD, with revenue projected to reach 199.39 million USD, implying an decrease of -74.26% EPS, and increase of 3.79% in Revenue from the last quarter.
FAQ
What were Supernus Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Supernus Pharmaceuticals, Inc. reported EPS of $1.01, beating estimates by 67.83%, and revenue of $192.10M, 5.28% above expectations.
How did the market react to Supernus Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved down -17.35%, changed from $57.00 before the earnings release to $47.11 the day after.
When is Supernus Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for 23. Feb. 2026.
What are the forecasts for Supernus Pharmaceuticals, Inc.'s next earnings report?
Based on 8
analysts, Supernus Pharmaceuticals, Inc. is expected to report EPS of $0.26 and revenue of $199.39M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung